This special webinar features Todd D. Levine, MD, Chief Medical Officer and Co-Founder of CND Life Sciences and the Syn-One Test®, a groundbreaking diagnostic tool that uses skin biopsies to detect abnormal alpha-synuclein, the protein linked to Parkinson’s disease and related conditions. Dr. Levine also shares insights on what’s on the horizon for future diagnostic developments and what this could mean for earlier detection, more accurate diagnoses, and improved care for people living with Parkinson’s.
